Investor sentiment post BTC ETF has been on the rise following the SEC decision on Bitcoin ETFs in January. This development, which is arguably the biggest in crypto’s history in terms of mainstream acceptance and adoption, has propelled the price of Bitcoin. Comfortably trading above $40,000, analysts predict a rise to $50,000 before its halving event.
At the same time, altcoins have been mirroring Bitcoin’s remarkable performance, notably Injective (INJ) and InQubeta (QUBE). With further upside anticipated, these are the best cryptos to buy now for staggering gains.
InQubeta (QUBE): Upward Trajectory Continues
InQubeta (QUBE) is among the new ICOs doing impressive numbers. Following a surge in interest earlier this week, it soared past $9.2 million in early funding, leaving early holders wide-eyed with excitement.
Its staggering upside potential as a top ICO is one of its biggest appeals—no surprise there. In the seventh stage of the presale, a token costs only $0.0224. Meanwhile, according to analysts, there will be a 60x price surge after its launch, positioning it as the best new crypto to invest in.
While its explosive growth potential has captured investor interest, there is so much more to it. As an AI altcoin, it is designed to solve critical issues within the fast-rising AI industry with blockchain.
Its upcoming crypto-based crowdfunding platform will allow AI tech startups to raise funds through cryptocurrency by minting investment opportunities. These tokenized real-world AI investments will be represented as equity-based NFTs, divided into bits, and offered to investors on the custom-built NFT marketplace.
Bitcoin (BTC): $50,000 Before its Halving?
The benefits of Bitcoin ETFs include gaining exposure to the digital asset without having to buy or store it, thereby creating a seamless experience. Traditional investors have been hopping on the crypto train, resulting in massive inflows and pushing the price of Bitcoin (BTC) up.
Another catalyst responsible for the surge in Bitcoin’s price is the anticipated halving, expected to occur in April—two months away. Typically, this event coincides with a rise in the price of Bitcoin, with investors hoping to have front-row experience and position themselves for significant gains.
According to analysts, Bitcoin will soar past $50,000 ahead of its halving—very bullish. This positions it as one of the best cryptos to invest in and a must-have crypto if you don’t already have it.
Injective (INJ): Uptrend Continues
Injective (INJ) is one of the altcoins benefiting from the ETF impact on crypto prices. It has been one of the best performers this year, with sights set on creating a new all-time high (ATH). Its substantial upside potential makes it one of the best coins to invest in.
In addition to its explosive growth potential, Injective plays a key role within the crypto space. As a blockchain built for finance, it powers next-generation DeFi (decentralized finance) applications.
With DeFi a crucial part of the crypto scene, Injective is set for massive adoption and growth. This makes it a compelling investment and a bullish wave not to miss out on. To avoid FOMO, grab a bag of INJ now.
Conclusion
The rise of Bitcoin has been a subject of much interest, with altcoins following closely behind. Injective and InQubeta are among the top altcoins experiencing a massive surge in interest as they skyrocket in their respective markets. If you wish to participate in the InQubeta presale, follow the link below.
